Company intelligence / Profile preview

CAS BioSciences

Paramus, New Jersey, United Statesgoedomega3.com ↗

Ownership: Private
Development stage: Commercial

Overview

CAS BioSciences is an active US-based manufacturer specializing in botanically and omega‐3 lipid derived ingredients for the nutraceuticals, pharmaceuticals (naturally-derived), food/beverage, cosmeceutical, and animal health/nutrition sectors. The company is recognized as a gold-standard supplier with stringent quality standards but does not appear to develop its own clinical-stage therapeutics.

Therapeutic areas: Other
Modalities: Botanically derived ingredientsOmega-3 lipid derived ingredients
Industry: Chemicals & Materials

Drug pipeline

1 asset

bovine lactoferrin

Commercial

Indications: COVID-19

Partnerships

No major pharmaceutical or biotech partnerships publicly disclosed. Recognized as a Preferred Supplier by NASC for quality compliance in supply chain management.

Beyond the preview

Go deeper on CAS BioSciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CAS BioSciences.

Explore the full profile